mail
versión imprimible
 
 

3rd World ADC Asia 2024

Evvnt Promotion / evvnt
-
25.06.2024 - 27.06.2024  Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, 22382 Jung-gu, Incheon, South Corea
Time: 8:00 am to 5:15 pm
 
Temas de la conferencia
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug development across the Asia-Pacific region. This part of the world is taking the ADC industry by storm with high-profile deals, multiple approvals, multiple ADCs moving into clinical trials, and novel targets being explored just to name some advancements.
La Sociedad Científica
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2191904-3?pid=4832

Speakers: Dohyun Nam, Chairman, Professor, Aimed Bio Inc., Jinwon Jung, Senior Directory, ABL Bio, Jia He, Senior Research Analyst Targeted Therapies, Beacon and More.
 

Información e inscripción:

https://go.evvnt.com/2191904-2?pid=4832
Ms. Jessica Durston
 
Categorías
Oncología
Idioma
Inglés
Cuota del Congreso
USD 1274.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationHelix - Forschung & Beratung WienEuropean Health Forum Gastein